Exact Sciences Corporation (NASDAQ:EXAS) has scheduled a conference call for 29th October 2020 at 5:00 PM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.exactsciences.com
Earnings Expectation
Exact Sciences Corporation is reporting third quarter financial results on Thursday 29th October 2020, after market close.
According to analysts surveyed by Thomson Reuters, EXAS is expected to report 3Q20 loss of $ 0.39 per share from revenue of $ 418.59 million.
For the full year, analysts anticipate top line of $ 1426.56 million, while looking forward to loss of $ 2.4 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 1,610.00 million ~ $ 1,645.00 million
Click Here For More Historical Outlooks Of Exact Sciences Corporation
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc.
